Contribute something unique about Galectin Therapeutics that may be helpful for others (ex. interview tips, choosing teams, unique culture, etc).
About
Galectin Therapeutics looks to help patients with NASH cirrhosis and cancer. Galectin’s lead drug (GR-MD-02, or belapectin) is a galectin-3 inhibitor.